Jiang DM - Search Results

1

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.

Jiang DM, Gupta S, Kitchlu A, Meraz-Munoz A, North SA, Alimohamed NS, Blais N, Sridhar SS. Jiang DM, et al. Nat Rev Urol. 2021 Feb;18(2):104-114. doi: 10.1038/s41585-020-00404-6. Epub 2021 Jan 11. Nat Rev Urol. 2021. PMID: 33432181 Review.

2

Prime time for immunotherapy in advanced urothelial cancer.

Jiang DM, Sridhar SS. Jiang DM, et al. Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:24-32. doi: 10.1111/ajco.13059. Asia Pac J Clin Oncol. 2018. PMID: 30489031 Review.

3

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.

Jiang DM, Jiang H, Chung PWM, Zlotta AR, Fleshner NE, Bristow RG, Berlin A, Kulkarni GS, Alimohamed NS, Lo G, Sridhar SS. Jiang DM, et al. Among authors: jiang h. Clin Genitourin Cancer. 2019 Feb;17(1):38-45. doi: 10.1016/j.clgc.2018.09.021. Epub 2018 Oct 4. Clin Genitourin Cancer. 2019. PMID: 30686350

4

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer.

Jiang DM, Fyles A, Nguyen LT, Neel BG, Sacher A, Rottapel R, Wang BX, Ohashi PS, Sridhar SS. Jiang DM, et al. Oncotarget. 2019 Apr 26;10(31):2947-2958. doi: 10.18632/oncotarget.26893. eCollection 2019 Apr 26. Oncotarget. 2019. PMID: 31105877 Free PMC article.

5

Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.

Jiang DM, Chung P, Kulkarni GS, Sridhar SS. Jiang DM, et al. Curr Oncol Rep. 2020 Feb 1;22(2):14. doi: 10.1007/s11912-020-0880-5. Curr Oncol Rep. 2020. PMID: 32008105 Review.

6

Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer.

Wong SE, Everest L, Jiang DM, Saluja R, Chan KKW, Sridhar SS. Wong SE, et al. Among authors: jiang dm. JCO Oncol Pract. 2020 Feb;16(2):e201-e210. doi: 10.1200/JOP.19.00421. Epub 2020 Jan 21. JCO Oncol Pract. 2020. PMID: 32045549

7

Transitioning to a New Normal in the Post-COVID Era.

Jiang DM, Berlin A, Moody L, Kumar R, Hannon B, Krzyzanowska MK, Dhani N, Cole H, Elliott M, Sridhar SS. Jiang DM, et al. Curr Oncol Rep. 2020 Jun 22;22(7):73. doi: 10.1007/s11912-020-00956-1. Curr Oncol Rep. 2020. PMID: 32566960 Free PMC article. Review. No abstract available.

8

Enfortumab Vedotin in urothelial cancer.

Alt M, Stecca C, Tobin S, Jiang DM, Sridhar SS. Alt M, et al. Among authors: jiang dm. Ther Adv Urol. 2020 Dec 27;12:1756287220980192. doi: 10.1177/1756287220980192. eCollection 2020 Jan-Dec. Ther Adv Urol. 2020. PMID: 33447264 Free PMC article. Review.

9

Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature.

Stecca CE, Alt M, Jiang DM, Chung P, Crook JM, Kulkarni GS, Sridhar SS. Stecca CE, et al. Among authors: jiang dm. Oncol Ther. 2021 Jun;9(1):21-39. doi: 10.1007/s40487-020-00135-z. Epub 2021 Jan 16. Oncol Ther. 2021. PMID: 33454930 Free PMC article. Review.

10

Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer.

Jiang DM, Fallah-Rad N, Lee R, Ng P, Smith AD, Hansen AR, Joshua AM, Beca J, Sridhar SS. Jiang DM, et al. Eur Urol. 2021 Feb;79(2):177-179. doi: 10.1016/j.eururo.2020.09.048. Epub 2020 Oct 21. Eur Urol. 2021. PMID: 33461737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page